These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4476417)

  • 21. The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man.
    Tolis G; Pinter EJ; Friesen HG
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):281-3. PubMed ID: 1165136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 23. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of methergoline and of a synthetic estrogen on plasmatic prolactin levels and on postpartum lactation].
    Boemi P; Pace G; Cianci A; Pellicciotta G; Palumbo G
    Minerva Ginecol; 1980 Mar; 32(3):135-42. PubMed ID: 6445525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine in refractory post partum lactation.
    Sathanandan M; Visvanathan T
    Ceylon Med J; 1976 Sep; 21(3):192-3. PubMed ID: 1037476
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl)].
    Jaszmann L; Sternthal V
    Geburtshilfe Frauenheilkd; 1974 Jan; 34(1):59-64. PubMed ID: 4816922
    [No Abstract]   [Full Text] [Related]  

  • 27. Lactation-inhibiting and prolactin-lowering effect of lisuride and transdihydrolisuride. A comparative study.
    Vĕtr M; Konecný V
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():295-300. PubMed ID: 2977904
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bromoergocryptine in the treatment of nonpuerperal galactorrhea].
    Hogh J
    Ugeskr Laeger; 1977 Jul; 139(29):1739-40. PubMed ID: 578342
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC; Sill AJ; Garthwaite TL; Halverson G; Borkowf HI
    Obstet Gynecol; 1980 Aug; 56(2):204-7. PubMed ID: 7190256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 31. The detection of lactogenic activity in human blood by bioassay.
    Forsyth IA
    J Endocrinol; 1970 Feb; 46(2):iv-v. PubMed ID: 5531075
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the influence of arginine aspartate in agalactia and hypogalactia].
    Tagliareni F; Tagliareni A
    Minerva Pediatr; 1977 Mar; 29(11):755-64. PubMed ID: 559913
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influencing the milk secretion with gestagens].
    Gyõry G; Kiss C
    Zentralbl Gynakol; 1968 May; 90(21):748-50. PubMed ID: 5686897
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radioimmunological evaluation of hormonal parameters in the stimulation and inhibition of lactogenesis].
    Montemagno U; Nappi C; Gravina E
    Arch Ostet Ginecol; 1976; 81(1-3):37-57. PubMed ID: 829968
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    Morin P; Engelmann P; Coustenoble G; Lebrun ; Gueris D
    Nouv Presse Med; 1975 Nov; 4(39):2811-2. PubMed ID: 1105425
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperprolactinemia in sarcoidosis.
    Turkington RW; MacIndoe JH
    Ann Intern Med; 1972 Apr; 76(4):545-9. PubMed ID: 4674338
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of hypogalactia with an extract of the betonica hedge nettle].
    Stegaĭlo EA; Lebedeva IM; Aronova BN; Bakhalova NV; Kharman DA
    Akush Ginekol (Mosk); 1980 Feb; (2):19-20. PubMed ID: 7369474
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of reserpine as a lactogenic substance].
    Mazhbits IA
    Akush Ginekol (Mosk); 1970 Jan; 46(1):70-2. PubMed ID: 5433043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.